Page last updated: 2024-09-05

deferasirox and oxazoles

deferasirox has been researched along with oxazoles in 1 studies

Compound Research Comparison

Studies (deferasirox)	Trials (deferasirox)	Recent Studies (post-2010) (deferasirox)	Studies (oxazoles)	Trials (oxazoles)	Recent Studies (post-2010) (oxazoles)
832	136	572	9,281	366	2,561

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Doucerain, C; Dürrenberger, F; Flace, A; Manolova, V; Nyffenegger, N	1

Other Studies

1 other study(ies) available for deferasirox and oxazoles

Article	Year
The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia. International journal of molecular sciences, 2021, Jan-16, Volume: 22, Issue:2 Topics: Administration, Oral; Animals; Benzimidazoles; beta-Thalassemia; Cation Transport Proteins; Cells, Cultured; Deferasirox; Drug Combinations; Drug Interactions; Erythropoiesis; Female; Iron; Iron Chelating Agents; Male; Mice; Mice, Inbred C57BL; Oxazoles; Pyridines; Transferrin	2021

Article

Year

The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia.

International journal of molecular sciences, 2021, Jan-16, Volume: 22, Issue:2

Topics: Administration, Oral; Animals; Benzimidazoles; beta-Thalassemia; Cation Transport Proteins; Cells, Cultured; Deferasirox; Drug Combinations; Drug Interactions; Erythropoiesis; Female; Iron; Iron Chelating Agents; Male; Mice; Mice, Inbred C57BL; Oxazoles; Pyridines; Transferrin

2021